CTC-TX Trademark

Trademark Overview

On Wednesday, March 14, 2012, a trademark application was filed for CTC-TX with the United States Patent and Trademark Office. The USPTO has given the CTC-TX trademark a serial number of 85569829. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, January 31, 2019. This trademark is owned by Vitatex Inc.. The CTC-TX trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic kits consisting primarily of culture plates, media, and reagents for use in isolating and labeling circulating tumor cells and circulating rare hematopoietic progenitor cells; Medical diagnostic reagents
ctc-tx

General Information

Serial Number85569829
Word MarkCTC-TX
Filing DateWednesday, March 14, 2012
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, January 31, 2019
Registration Number4464166
Registration DateTuesday, January 7, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDiagnostic kits consisting primarily of culture plates, media, and reagents for use in isolating and labeling circulating tumor cells and circulating rare hematopoietic progenitor cells; Medical diagnostic reagents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 23, 2012
Primary Code005
First Use Anywhere DateFriday, January 14, 2011
First Use In Commerce DateFriday, January 14, 2011

Trademark Owner History

Party NameVitatex Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressStony Brook, NY 117903350
Party NameVitatex Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStony Brook, NY 117903350

Trademark Events

Event DateEvent Description
Thursday, January 31, 2019NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED
Thursday, January 31, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, January 31, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 8, 2019TEAS SECTION 8 RECEIVED
Monday, January 7, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 7, 2014REGISTERED-SUPPLEMENTAL REGISTER
Thursday, December 5, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 2, 2013ASSIGNED TO LIE
Thursday, November 7, 2013APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, October 21, 2013EXAMINER'S AMENDMENT ENTERED
Monday, October 21, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 21, 2013EXAMINERS AMENDMENT E-MAILED
Monday, October 21, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, August 19, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 19, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 19, 2013NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, February 18, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 18, 2013NON-FINAL ACTION E-MAILED
Monday, February 18, 2013NON-FINAL ACTION WRITTEN
Monday, February 18, 2013USE AMENDMENT ACCEPTED
Tuesday, December 18, 2012AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, December 18, 2012USE AMENDMENT FILED
Monday, December 17, 2012TEAS AMENDMENT OF USE RECEIVED
Thursday, June 28, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 28, 2012NON-FINAL ACTION E-MAILED
Thursday, June 28, 2012NON-FINAL ACTION WRITTEN
Wednesday, June 20, 2012ASSIGNED TO EXAMINER
Friday, March 23, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 17, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

circulating cells reagents diagnostic tumor rare medical progenitor hematopoietic isolating